MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care SettingCLINICAL INFECTIOUS DISEASESIF7.32014-02-18129OA
An Official American Thoracic Society Statement: Treatment of Fungal Infections in Adult Pulmonary and Critical Care PatientsAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINEIF19.42011-01-01468PREAI
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of AmericaCLINICAL INFECTIOUS DISEASESIF7.32010-02-012.1KOA
Commentary: IDSA Guidelines for Improving the Teaching of Preclinical Medical Microbiology and Infectious DiseasesACADEMIC MEDICINEIF5.22010-01-0125OAAI
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses study group and European Organization for Research and Treatment of Cancer consensus criteriaCLINICAL INFECTIOUS DISEASESIF7.32008-09-01387OAAI
Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of AmericaCLINICAL INFECTIOUS DISEASESIF7.32008-06-15424PREAI
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus GroupCLINICAL INFECTIOUS DISEASESIF7.32008-06-154.2KOAAI
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care settingEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASESIF32007-02-27296PREAI
Clinical research in the lay press: Irresponsible journalism raises a huge dose of doubtCLINICAL INFECTIOUS DISEASESIF7.32006-10-153OAAI
Invasive fungal infections in low-risk liver transplant recipients: A multi-center prospective observational study低危肝移植受者侵袭性真菌感染的多中心前瞻性观察研究AMERICAN JOURNAL OF TRANSPLANTATIONIF8.22006-02-0199OA
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS clinical trials group study 323/Mycoses Study Group Study 40CLINICAL INFECTIOUS DISEASESIF7.32005-11-1548OAAI
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52005-03-01202OAAI
A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patientsCLINICAL INFECTIOUS DISEASESIF7.32003-09-01715PREAI
Introduction to the forum report on advances in the design of antifungal clinical trialsCLINICAL INFECTIOUS DISEASESIF7.32003-04-151OAAI
Preface to the forum report on advances in the design of antifungal clinical trialsCLINICAL INFECTIOUS DISEASESIF7.32003-04-150OAAI
Forum report: Issues in the design of trials of drugs for the treatment of invasive aspergillosisCLINICAL INFECTIOUS DISEASESIF7.32003-04-157OAAI
Forum report: Issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groupsCLINICAL INFECTIOUS DISEASESIF7.32003-04-159OAAI
Forum report: Issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patientsCLINICAL INFECTIOUS DISEASESIF7.32003-04-1548OAAI
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapyCLINICAL INFECTIOUS DISEASESIF7.32001-09-01514OAAI